iBio, Inc. (IBIO) Financial Statements
iBio, Inc. (IBIO) files with the U.S. Securities and Exchange Commission under CIK 0001420720. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2026
- Revenue
- $100.00 thousand
- Net Income
- -$33.04 million
- Total Assets
- $99.11 million
- Net Cash from Operations
- -$23.22 million
Fiscal year ended Jun 30, 2026. Latest periodic SEC filing: Aug 28, 2026. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for IBIO in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History